share_log

HC Wainwright & Co. Initiates Coverage On Anebulo Pharmaceuticals With Buy Rating, Announces Price Target of $6

HC Wainwright & Co. Initiates Coverage On Anebulo Pharmaceuticals With Buy Rating, Announces Price Target of $6

HC Wainwright & Co.以买入评级开始对Anebulo Pharmicals进行报道,宣布目标股价为6美元
Benzinga ·  2023/09/18 06:33

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy rating and announces Price Target of $6.

HC Wainwright&Co.分析师Raghuram Selvaraju以买入评级启动对AneBulo制药(纳斯达克:ANEB)的报道,并宣布目标价为6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发